University of Kentucky |  UK HealthCare |  News and Events |  Give to Medicine |  About Our College |   Share Accomplishments
UK College of Medicine logo

Current
Students
Prospective
Students
Residents
& Fellows
Graduate Students
& Postdoctoral Fellows
Faculty
& Staff
Alumni
Association
ed1 rs1 cs4 ad1

Radiation Medicine

GENERAL

EDUCATION

RESEARCH

CLINICAL SERVICES

Return Back to Radiation Medicine Faculty & Doctor Directory

Photo of Vivek RangnekarVivek Rangnekar, Ph.D.
Professor and Research Scientist
Combs Research Building
744 Rose Street 326
Lexington, KY 40536
Phone: (859) 257-2677
Email: vivek@ms.uky.edu

 

 

 

RESEARCH INTERESTS:

  • Cancer
  • Apoptosis
  • Tumor Suppressors
  • Cell Signaling

EDUCATION:

  • B.S., University of Bombay, 1976
  • M.S., University of Bombay, 1979
  • Ph.D., University of Bombay, 1983

SELECTED PUBLICATIONS:

Book Chapters (invited, non-peer-reviewed)

VM Rangnekar, M.P. Mattson (2000), Pivotal role of the leucine zipper domain protein Par-4 in neuronal cell apoptosis: in Recent Research Developments in Neurochemistry (Research Signpost, Trivandrum). Volume 3, 125-134. * corresponding author

VM Rangnekar (2001), Apoptosis by Par-4 protein. Programmed Cell Death: Cellular and Molecular Mechanisms. (Elsevier Science, Inc., NY). Editors: M. P. Mattson, S. Estus, and V. M. Rangnekar.Volume 1, pp.215-236.

P Ranganathan, VM. Rangnekar (2005) Regulation of Cancer Cell Survival by Par-4. Ann. New York Acad. Sci. 1059, 76-85.

KM. Vasudevan, P. Ranganathan, VM. Rangnekar (2005) Regulation of Par-4 by oncogenic Ras.  Methods in Enzymology.  (Elsevier Science, Inc., NY). Editors: Bill Balch, Channing Der, Alan Hall. Volume 407, pp. 422-442.

Give to Medicine  |  Privacy  |  Jobs  |  News  |  Directions  |  UK Home   |  UK Medical Center
© 2008, University of Kentucky College of Medicine, 800 Rose St., Lexington, Kentucky, USA 40536-0298, Phone (859) 323-5000
Please send us Comments and Corrections |  An Equal Opportunity University |  Terms, Conditions & Privacy and Accessibility Statements
Page last updated Sunday, March 16, 2008